This HTML5 document contains 178 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
wdthttp://www.wikidata.org/prop/direct/
wdtnhttp://www.wikidata.org/prop/direct-normalized/
n11http://dx.doi.org/10.1517/
schemahttp://schema.org/
rdfshttp://www.w3.org/2000/01/rdf-schema#
skoshttp://www.w3.org/2004/02/skos/core#
wikibasehttp://wikiba.se/ontology#
phttp://www.wikidata.org/prop/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
n10http://rdf.ncbi.nlm.nih.gov/pubchem/reference/
xsdhhttp://www.w3.org/2001/XMLSchema#
wdshttp://www.wikidata.org/entity/statement/
wdhttp://www.wikidata.org/entity/

Statements

Subject Item
wd:Q36040879
rdf:type
wikibase:Item
schema:description
научни чланак 2005年学术文章 научна статия 2005年學術文章 artículu científicu espublizáu en 2005 գիտական հոդված tudományos cikk articol științific مقالة علمية نشرت في عام 2005 artigo científico სამეცნიერო სტატია наукова стаття, опублікована в січні 2005 2005年學術文章 2005 nî lūn-bûn 2005年学术文章 bài báo khoa học บทความทางวิทยาศาสตร์ سائنسی مضمون scienca artikolo artikull shkencor мақолаи илмӣ 2005年學術文章 vědecký článek naučni članak artigo científico (publicado na 2005) vitenskapelig artikkel научная статья bilimsel makale mokslinis straipsnis 2005年学术文章 מאמר מדעי vitskapeleg artikkel vetenskaplig artikel article científic 2005年学术文章 мақолаи илмӣ wissenschaftlicher Artikel 2005年学术文章 videnskabelig artikel (udgivet 2005) vedecký článok wetenschappelijk artikel scientific article 2005年學術文章 artykuł naukowy articolo scientifico tieteellinen artikkeli teaduslik artikkel artikulong pang-agham επιστημονικό άρθρο 2005年の論文 2005年學術文章 article scientific научни чланак مقالهٔ علمی artigo científico (publicado na 2005) article scientifique (publié 2005) 2005년 논문 ২০০৫-এ প্রকাশিত বৈজ্ঞানিক নিবন্ধ 2005年學術文章 artículo científico publicado en 2005
p:P577
wds:Q36040879-12375B35-8759-4D0C-95FB-0A2FA3B8278A
wdt:P577
2005-01-01T00:00:00Z
p:P407
wds:Q36040879-A0FAB921-D258-4B15-9175-2B1DF55BEF80
wdt:P407
wd:Q1860
p:P2860
wds:Q36040879-12D3F220-5490-401C-BA2D-DB18C4E708AE wds:Q36040879-1511605C-0F05-4AE2-8B77-FABB5E200887 wds:Q36040879-160BD372-A501-400B-AC31-BE3F4A47BFE5 wds:Q36040879-1F85129A-B08C-4DFF-B9C2-DAF9B7B85C8A wds:Q36040879-20CF70E6-2947-4285-A308-CA8DAB244557 wds:Q36040879-23BA17A9-4A61-4926-A1E8-FB8F89C3BE54 wds:Q36040879-261E9008-AE6F-4542-8635-430821B614A5 wds:Q36040879-270C0CFA-0EEA-483A-A859-53D33343D6C4 wds:Q36040879-31EF5CC9-9401-4997-879F-B002FC9E9747 wds:Q36040879-3763C146-0F7B-43D6-9ABE-43CBBF4D5B7E wds:Q36040879-3884C802-AB64-445F-85E4-55E2B4053DAC wds:Q36040879-3B6EEBC2-EE90-42B6-9559-A6083C097B53 wds:Q36040879-4C6F8ED4-034A-47EA-B657-4EA0F93A76BB wds:Q36040879-535FB4A1-F41D-4EC7-B39B-AAD82FF48800 wds:Q36040879-5443C35F-8A65-46A5-AEE1-1AB2F6835267 wds:Q36040879-5BD33F0B-3274-47C5-BAB2-60CE89863762 wds:Q36040879-656C1D72-8290-40E8-A2F2-245B98885E04 wds:Q36040879-6F3F3240-2442-48C1-8F1E-1D3D2BB9EC36 wds:Q36040879-73EF3AB2-DDD2-48D4-B011-21C7BE3DC15F wds:Q36040879-74BAD99C-700E-4CE2-9FAC-D2BAE078A37F wds:Q36040879-757AF6C1-0B69-4B80-B816-DA4A46EE3A09 wds:Q36040879-843AAB70-832C-490A-BF05-1E2286C176C4 wds:Q36040879-845BFC5F-CE10-4D4D-B837-A6E56F284C8A wds:Q36040879-8F2E2DAD-30B6-47A9-992A-A72B53D71BCC wds:Q36040879-98F44283-C580-42DD-96B4-82E74912B817 wds:Q36040879-9DC36B28-F063-49AD-BD43-85284CA72948 wds:Q36040879-9E9F6605-E542-4F62-B12F-8B98CC87DA44 wds:Q36040879-A0A5FE07-5CD2-47EC-AE0E-79984D803103 wds:Q36040879-A131F07D-3EAA-4913-B8BA-D8F249CC2C5C wds:Q36040879-A8C1F28F-B588-4E73-ACBF-24A69B049C7F wds:Q36040879-A8C3110D-03FA-4787-89B4-676AC06419AD wds:Q36040879-A9973AE5-ADDA-420E-8ECE-403AA31102D2 wds:Q36040879-B4FB597D-150E-4E0C-80B9-1D1F7E914002 wds:Q36040879-B5A29CE7-7842-4E55-8DF6-6917C8EE1E6C wds:Q36040879-B9C34703-FE16-4474-A21D-2F3E4ADF5E10 wds:Q36040879-DCD49DDA-B8E0-4E10-A23C-3E2235287107 wds:Q36040879-E97B9486-4570-4CF7-868B-A54E718E209C wds:Q36040879-ECB01F22-FE09-4852-B1FB-7B959B40BD01 wds:Q36040879-F249E95D-1754-4845-8C28-7D3BD9377794 wds:Q36040879-F7E9F630-91B8-4AF8-9CFB-84A66BB91553
wdt:P2860
wd:Q35206949 wd:Q34368489 wd:Q36056970 wd:Q42435174 wd:Q28199376 wd:Q45041579 wd:Q34060758 wd:Q34346667 wd:Q35618856 wd:Q28117412 wd:Q39564545 wd:Q44400093 wd:Q34530843 wd:Q35809679 wd:Q43972608 wd:Q43913927 wd:Q28258745 wd:Q34026346 wd:Q42169660 wd:Q44865459 wd:Q33788748 wd:Q35545683 wd:Q35818705 wd:Q33799839 wd:Q35098627 wd:Q45124469 wd:Q35615343 wd:Q58864229 wd:Q35688209 wd:Q42519283 wd:Q44320631 wd:Q44526985 wd:Q27640960 wd:Q35669308 wd:Q24290340 wd:Q35144434 wd:Q40615308 wd:Q35086817 wd:Q27640163 wd:Q42603059
p:P2093
wds:Q36040879-2083DE9E-9DD4-421C-AD32-CDE59F79FE5B
wdt:P2093
Rolf Mentlein
rdfs:label
Therapeutic assessment of glucagon-like peptide-1 agonists compared with dipeptidyl peptidase IV inhibitors as potential antidiabetic drugs Therapeutic assessment of glucagon-like peptide-1 agonists compared with dipeptidyl peptidase IV inhibitors as potential antidiabetic drugs Therapeutic assessment of glucagon-like peptide-1 agonists compared with dipeptidyl peptidase IV inhibitors as potential antidiabetic drugs
skos:prefLabel
Therapeutic assessment of glucagon-like peptide-1 agonists compared with dipeptidyl peptidase IV inhibitors as potential antidiabetic drugs Therapeutic assessment of glucagon-like peptide-1 agonists compared with dipeptidyl peptidase IV inhibitors as potential antidiabetic drugs Therapeutic assessment of glucagon-like peptide-1 agonists compared with dipeptidyl peptidase IV inhibitors as potential antidiabetic drugs
schema:name
Therapeutic assessment of glucagon-like peptide-1 agonists compared with dipeptidyl peptidase IV inhibitors as potential antidiabetic drugs Therapeutic assessment of glucagon-like peptide-1 agonists compared with dipeptidyl peptidase IV inhibitors as potential antidiabetic drugs Therapeutic assessment of glucagon-like peptide-1 agonists compared with dipeptidyl peptidase IV inhibitors as potential antidiabetic drugs
p:P1476
wds:Q36040879-C7B30BE5-B556-42C4-82DD-FC7820C9E59D
wdt:P1476
Therapeutic assessment of glucagon-like peptide-1 agonists compared with dipeptidyl peptidase IV inhibitors as potential antidiabetic drugs
p:P304
wds:Q36040879-EAC5E534-3504-4D08-8027-6D02D3410F93
wdt:P304
57-64
p:P31
wds:Q36040879-9D65DD45-DFA0-4AC5-A2DC-8C51D6BF38E9 wds:Q36040879-4f043a64-598f-46e8-bc10-4c30d29ec7f5
wdt:P31
wd:Q13442814 wd:Q7318358
p:P698
wds:Q36040879-5FDDAEB9-BDEE-4B4A-A42A-E88D48A800A3
wdtn:P698
n10:15709922
wdt:P698
15709922
p:P1433
wds:Q36040879-DBB39A1F-7CBD-4479-9DA5-800313ED3CDF
wdt:P1433
wd:Q5421208
p:P433
wds:Q36040879-40837892-8047-45BD-B129-D9EA2AC1C1D7
p:P478
wds:Q36040879-6856E296-68A2-460D-A7C6-36B27BBE6295
wdt:P433
1
wdt:P478
14
p:P356
wds:Q36040879-09E6B511-E39D-4886-94C0-9EFDCEEF5141
wdtn:P356
n11:13543784.14.1.57
wdt:P356
10.1517/13543784.14.1.57
p:P8608
wds:Q36040879-F8B5C43A-7ACC-452F-A204-4C5967DD1C75
wdt:P8608
release_jyuvla4xajhg7pqlwmi2rophau